Summary Comments
- Most frequently detected viruses during October (all age groups):
- Rhino/Enterovirus: 28.2%
- Rhinovirus: 23.1%
- Metapneumovirus: 10.1%
- Epidemiological Week 1–44:
- SARS-CoV-2: Stable over the last 4 weeks
- Influenza A: Peaked at 43.6% in week 20, declined to 1.2% in week 44
- Influenza B: Peaked at 26% in week 31, declined to 1% in week 44
- RSV: Peaked at 27.8% in week 13, declined to 1% in week 44
Respiratory Viral Multiplex PCR and SARS-CoV-2 PCR: All Age Groups
September 2024:
- Rhino/Enterovirus: 27.5%
- Rhinovirus: 23.1%
- SARS-CoV-2: 7.5%
- Metapneumovirus: 10.4%
- Parainfluenza 1–4: 9.3%
- Adenovirus: 3.1%
- Influenza A: 2%
- Influenza B: 1.2%
- RSV: 1.7%
October 2024:
- Rhino/Enterovirus: 28.2%
- Rhinovirus: 23.1%
- SARS-CoV-2: 7.5%
- Metapneumovirus: 10.1%
- Parainfluenza 1–4: 10.1%
- Adenovirus: 2.9%
- Influenza A: 1.2%
- Influenza B: 1%
- RSV: 1.7%
Atypical Bacterial Pathogens (Weeks 1–44)
Detected Pathogens:
- B. pertussis, M. pneumoniae, C. pneumoniae
- 1 case of Legionella pneumophila in October
Age Distribution:
Bordetella pertussis:
- 0–6 months: 16%
- 6–12 months: 7%
- 1–5 years: 30%
- 6–12 years: 19%
- 13–18 years: 2%
- 19–64 years: 18%
65 years: 8%
Mycoplasma pneumoniae:
- 0–6 months: 2%
- 6–12 months: 6%
- 1–5 years: 26%
- 6–12 years: 30%
- 13–18 years: 3%
- 19–64 years: 24%
65 years: 4%
Chlamydia pneumoniae:
- 0–6 months: 2%
- 6–12 months: 3%
- 1–5 years: 46%
- 6–12 years: 31%
- 13–18 years: 8%
- 19–64 years: 14%
65 years: 1%
Paediatric Respiratory Viral Multiplex PCR Data (Ages 0–12)
<1 Year Age Group
September 2024:
- Rhino/Enterovirus: 40.7%
- Rhinovirus: 42.1%
- Parainfluenza 1–4: 17.6%
- Metapneumovirus: 14%
- SARS-CoV-2: 10.7%
- Adenovirus: 13.5%
- Influenza A: 0.9%
- Influenza B: 0.7%
- RSV: 3.6%
October 2024:
- Rhino/Enterovirus: 42.1%
- Rhinovirus: 35.0%
- Parainfluenza 1–4: 17.5%
- Metapneumovirus: 14%
- SARS-CoV-2: 11.3%
- Adenovirus: 7.8%
- Influenza A: 1.1%
- Influenza B: 0.4%
- RSV: 0.3%
1–5 Year Age Group
September 2024:
- Rhino/Enterovirus: 48.6%
- Rhinovirus: 35.8%
- Adenovirus: 19.2%
- Parainfluenza 1–4: 15.6%
- SARS-CoV-2: 11.5%
- Enterovirus: 18.1%
- Influenza A: 1.2%
- Influenza B: 0.6%
- RSV: 1.1%
October 2024:
- Rhino/Enterovirus: 48.6%
- Rhinovirus: 35.1%
- Adenovirus: 19.2%
- Parainfluenza 1–4: 15.6%
- SARS-CoV-2: 10.7%
- Enterovirus: 16.6%
- Influenza A: 2.9%
- Influenza B: 0.6%
- RSV: 0.3%
6–12 Year Age Group
September 2024:
- Rhino/Enterovirus: 40.4%
- Rhinovirus: 36.1%
- Influenza B: 25.4%
- SARS-CoV-2: 7.0%
- Adenovirus: 6.2%
- Parainfluenza 1–4: 7.3%
- RSV: 0.4%
- Influenza A: 0.8%
October 2024:
- Rhino/Enterovirus: 42.8%
- Rhinovirus: 37.7%
- Influenza B: 3.1%
- SARS-CoV-2: 8.1%
- Adenovirus: 7.3%
- Parainfluenza 1–4: 3.4%
- RSV: 0.3%
- Influenza A: 0.7%
Key Age Group Highlights (October 2024):
- <1 year:
- Rhino/Enterovirus (42.1%), Rhinovirus (35%), Parainfluenza 1–4 (17.5%), Metapneumovirus (14%)
- 1–5 years:
- Rhino/Enterovirus (48.6%), Rhinovirus (35.1%), Adenovirus (19.2%), Parainfluenza 1–4 (15.6%)
- 6–12 years:
- Rhino/Enterovirus (42.8%), Rhinovirus (37.7%)
- Influenza B declined from 25.4% in September to 3.1% in October
Continue Reading